Your browser doesn't support javascript.
loading
Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kodama, Yuichi; Manabe, Atsushi; Kawasaki, Hirohide; Kato, Itaru; Kato, Keisuke; Sato, Atsushi; Matsumoto, Kimikazu; Kato, Motohiro; Hiramatsu, Hidefumi; Sano, Hideki; Kaneko, Takashi; Oda, Megumi; Saito, Akiko M; Adachi, Souichi; Horibe, Keizo; Mizutani, Shuki; Ishii, Eiichi; Shimada, Hiroyuki.
Affiliation
  • Kodama Y; Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Manabe A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Kawasaki H; Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
  • Kato I; Department of Pediatrics, Kansai Medical University Hirakata Hospital, Osaka, Japan.
  • Kato K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sato A; Department of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito, Japan.
  • Matsumoto K; Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
  • Kato M; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Hiramatsu H; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Sano H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kaneko T; Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan.
  • Oda M; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Saito AM; Department of Pediatric Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Adachi S; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Horibe K; Human Health Sciences, Kyoto University, Kyoto, Japan.
  • Mizutani S; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Ishii E; Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan.
  • Shimada H; Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan.
Pediatr Blood Cancer ; 64(8)2017 Aug.
Article in En | MEDLINE | ID: mdl-28084041
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Imatinib Mesylate Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2017 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Imatinib Mesylate Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2017 Type: Article Affiliation country: Japan